2024
DOI: 10.2147/ppa.s472478
|View full text |Cite
|
Sign up to set email alerts
|

Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World Data

Sandra Michiels,
Sandra Tricas-Sauras,
Adriano Salaroli
et al.

Abstract: Purpose Imatinib adherence and persistence are key components of the successful treatment of Chronic Myeloid Leukemia (CML). In Belgium, there is no study assessing these behaviors at a national level. Our study aimed to provide the first nationwide measure and to identify associated pharmacy-based predictors (age, gender, comorbidities). We also assessed mortality and transplantation incidence according to adherence status. Methods Based on medico-administrative databa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 61 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?